BioLife Solutions Inc
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from BioLife Solutions Inc's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 26% in 3 years; of every extra $100 of sales, $677 became extra profit. Higher than 95% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 2 of the last 3 years; profit grew in 3 of 3. Steadier than 85% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
0.5×Over the last 3 years its own operating cash paid for 54% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Higher than 66% of Healthcare companies in United States.
Cash Locked Ratio
$36For every $100 of sales, $36 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $63 tied up three years earlier.
More money tied up than 75% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 3/3Sales grew in 2 of the last 3 years; profit grew in 3 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$677Sales grew 26% in 3 years; of every extra $100 of sales, $677 became extra profit.
Higher than 95% of Healthcare companies in United States.
Asset Productivity Ratio
+26% / -10%In 3 years sales changed by +26% while total assets changed by -10%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
4.0×Debt due within a year is covered 4.0 times by its yearly operating cash.
Higher than 78% of Healthcare companies in United States.
Cash Cushion Ratio
+4%Cash, after subtracting all debt, equals 4% of its market value (net cash).
Lower than 60% of Healthcare companies in United States.
Tangible Assets Ratio
48%Of every $100 the company owns, $48 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 83% of Healthcare companies in United States.
Tangible Net Worth Ratio
43%Of every $100 of net worth, $43 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 56% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
BioLife Solutions Inc owes $0.06 for every $1 it owns. BioLife Solutions Inc made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
39.0Investors pay $39.0 for every $1 of BioLife Solutions Inc's yearly profit, higher than 71% of Healthcare companies in United States.
P/B ratio
4.50The share price is 4.50 times BioLife Solutions Inc's book value per share, higher than 69% of Healthcare companies in United States.
Market cap
$1.9 BThe total market value of all of BioLife Solutions Inc's shares at today's price (share price × number of shares), larger than 74% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$420 MWhat BioLife Solutions Inc would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$8.58Net worth divided by the number of shares. The share price of $38.61 is 4.5 times this, which is the P/B above.
Return on equity (ROE)
12.8%BioLife Solutions Inc earned 12.8% on its shareholders' money over the last year, higher than 86% of Healthcare companies in United States.
Owes vs Owns
0.06×BioLife Solutions Inc owes $0.06 for every $1 it owns (low), lower than 94% of Healthcare companies in United States.
Dividend yield
NoneBioLife Solutions Inc does not currently pay a dividend.
Revenue growth
+29%Revenue rose 29% in the year to Dec 2025, and grew 8% a year on average over 3 years.
Profit growth
LossBioLife Solutions Inc made a loss in each of the last two years.
Profit margin
-4.8%BioLife Solutions Inc lost $5 for every $100 of revenue.
Cash vs debt
Net cashBioLife Solutions Inc held $71 M more cash than debt (net cash) at Dec 2025.
Questions
What is BioLife Solutions Inc's P/E ratio?
Investors pay $39.0 for every $1 of BioLife Solutions Inc's yearly profit, higher than 71% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For BioLife Solutions Inc: $1.9 B ÷ $420 M (30 Jun 2026) = 4.5.
What is BioLife Solutions Inc's return on equity?
BioLife Solutions Inc earned 12.8% on its shareholders' money over the last year, higher than 86% of Healthcare companies in United States.
How much does BioLife Solutions Inc owe compared with what it owns?
BioLife Solutions Inc owes $0.06 for every $1 it owns (low), lower than 94% of Healthcare companies in United States.
Does BioLife Solutions Inc pay a dividend?
No. BioLife Solutions Inc does not currently pay a dividend.
Is BioLife Solutions Inc's revenue growing?
Revenue rose 29% in the year to Dec 2025, and grew 8% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.